While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Eli Lilly's newest medicines for diabetes and obesity, Mounjaro and Zepbound ... so investors' expectations are sky-high. See ...

AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...

One of the more significant challenges we face as parents is making sure our kids are growing at a healthy rate.Author Nick Fuller Clinical Trials ...

Real-time index price for TSX Composite Weight Index (TXCE), along with buy or sell indicators, analysis, charts, historical ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

When you need to work with the health care provider you have, here’s how to advocate for yourself, even while wearing a skimpy gown.

Related Text-messaging program helps parents prevent obesity in young children Ozempic ... focused on almost 15,000 adult ...

Tim Spector says one type of food linked to diabetes, obesity and heart disease All Blacks v Ireland: Codie Taylor’s absence ...

Viking Therapeutics (VKTX) surges on promising obesity drug results. Explore key price levels and analyst insights in this detailed analysis.

Pudgy pets are a problem in America. According to the Association for Pet Obesity Prevention, a shocking 56% of dogs and 60% ...